Biotechnology in medicine
Biotechnology in medicine involves the use of biomedical engineering, genetic engineering and molecular biology to advance diagnostics, drug development and treatment effectiveness. The field of study helps advance medical research and patient care through an increased understanding of genetic and molecular processes underlying health and disease.
Top Stories
-
News
02 Jun 2026
Pfizer, Innovent strike $10B cancer drug deal
Involving up to 12 antibody drugs, the alliance is the latest broad partnership between Chinese biotech and a multinational pharmaceutical company. Continue Reading
-
Feature
13 May 2026
Why the FDA’s push for real-time clinical trials could favor Big Pharma
The agency’s new initiative promises faster drug approval times, but smaller trial sponsors could struggle to keep up. Continue Reading
-
Feature
29 Apr 2026
Obesity drugmakers chase weight loss. Biohaven is betting on muscles
With many pharma companies focused on developing drugs that shed pounds, Biohaven is digging its heels into a clinical program based on an experimental myostatin inhibitor that builds muscle. Continue Reading
-
News
28 Apr 2026
Boehringer's dual agonist obesity drug spurs up to 16.6% weight loss
Boehringer Ingelheim's dual-acting obesity shot led to weight loss comparable to Wegovy but could potentially help patients preserve more muscle mass. Continue Reading
-
News
23 Apr 2026
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a late-stage test that could support a future approval. Continue Reading
-
News
25 Feb 2026
Novo teams up with Vivtex to develop oral metabolic biologics
Novo Nordisk doubles down on oral drug delivery for the development of next-generation obesity and diabetes biologics, striking a licensing deal with Vivtex valued at up to $2.1 billion. Continue Reading
-
News
30 Jan 2026
Oracle launches AI data tool to expedite life sciences research
Oracle's new GenAI data platform was built to help pharmaceutical and life sciences companies speed up drug research and development using real-world health datasets. Continue Reading
-
News
20 Jan 2026
Novo expands diabetes partnership with Aspect Biosystems
Novo Nordisk and Canadian bioprinting company Aspect Biosystems build on their 2023 deal to develop cell-based treatments for diabetes. Continue Reading
-
News
14 Jan 2026
Trust concerns hinder agentic AI adoption, orchestration
Despite significant investment, most pharmaceutical and life sciences companies are struggling to bring agentic AI into production, a new report says. Continue Reading
-
News
02 Oct 2025
How TrumpRx could affect PBMs, specialty pharmacies, biotech
TrumpRx's transparent cash pricing could disrupt PBM rebate models, specialty pharmacy contracts and biotech's commercialization approaches, depending on uptake, experts say. Continue Reading
-
Feature
01 Oct 2025
2026's top healthcare and pharma conferences
From revenue cycle management strategies to digital transformation, healthcare and pharma leaders can learn from some of the industry's biggest events. Continue Reading
-
Feature
11 Mar 2025
Exploring FDA-approved biosimilar insulin products
FDA-approved biosimilar insulin products, such as Semglee, Rezvoglar and Merilog, expand access and provide cost-effective alternatives to reference biologics. Continue Reading
-
News
12 Dec 2024
USPSTF proposes guidelines for cervical cancer screening
With the advent of new self-collection methods for HPV testing, the USPSTF has proposed draft guidelines for cervical cancer screening that include patient-collected HPV tests. Continue Reading
-
News
11 Dec 2024
ARPA-H awards startup $3 million for home preeclampsia test
Gravidas Diagnostics received $3 million from ARPA-H to develop a home fingerstick preeclampsia test that detects sFlt‐1 levels in the bloodstream using a colorimetric assay. Continue Reading
-
Feature
10 Dec 2024
2025 life sciences industry outlook: What's next?
A 2025 life sciences industry outlook report identifies several focus areas, including digital transformation, competitive pressures, business volatility and evolving customer needs. Continue Reading
-
Feature
25 Nov 2024
Exploring the secondary prevention of cervical cancer
Molecular tests, sampling, cytologic techniques, visual assessment and precancer treatment play a critical tool in the secondary prevention of cervical cancer. Continue Reading
-
Feature
04 Nov 2024
AMPEL develops a blood test for cardiovascular disease
Amrie Grammer, AMPEL's co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company's CardioGENE blood test for cardiovascular disease risk. Continue Reading
-
Feature
28 Oct 2024
Addressing gene and cell therapy commercialization challenges
InspiroGene addresses some gene and cell therapy commercialization challenges by offering logistics programs, distribution services, a biologics specialty pharmacy and a patient hub. Continue Reading
-
News
24 Sep 2024
FDA approves self-administered nasal influenza vaccine
By the 2025-2026 respiratory virus season, FluMist, the nasal influenza vaccine, will be available for home vaccination via self- or caregiver-administration to eligible patients. Continue Reading
-
Feature
19 Sep 2024
Using synthetic biomarkers for early cancer detection
Using a synthetic targeting platform that forces cancer cells to express synthetic biomarkers, Earli Inc. is developing strategies for early cancer detection. Continue Reading
-
Answer
14 Aug 2024
Could Roche’s malaria test help address the national blood shortage?
Strategies for ending the national blood shortage may include expanding the donor pool, rationing, and diagnostic tests. Continue Reading